Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

Over 75% of depressed patients suffer from painful symptoms predicting a greater severity and a less favorable outcome of depression. Imaging, anatomical and functional studies have demonstrated the existence of common brain structures, neuronal pathways and neurotransmitters in depression and pain....

Full description

Bibliographic Details
Main Authors: Bruno P. Guiard, Alain M. Gardier, Guillaume Hache, François Coudore
Format: Article
Language:English
Published: MDPI AG 2011-01-01
Series:Pharmaceuticals
Subjects:
antidepressant
serotonin
norepinephrine
dopamine
monoamine transporters
mood disorders
pain
SSRI
NRI
SNRI
triple reuptake inhibitors
Online Access:http://www.mdpi.com/1424-8247/4/2/285/

Internet

http://www.mdpi.com/1424-8247/4/2/285/

Similar Items